HK1205507A1 - Protein kinase inhibitors - Google Patents
Protein kinase inhibitorsInfo
- Publication number
- HK1205507A1 HK1205507A1 HK15106058.9A HK15106058A HK1205507A1 HK 1205507 A1 HK1205507 A1 HK 1205507A1 HK 15106058 A HK15106058 A HK 15106058A HK 1205507 A1 HK1205507 A1 HK 1205507A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- protein kinase
- kinase inhibitors
- inhibitors
- protein
- kinase
- Prior art date
Links
- 229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
- 239000003909 protein kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/561,960 US8859553B2 (en) | 2012-07-30 | 2012-07-30 | Protein kinase inhibitors |
PCT/CN2013/000897 WO2014019338A1 (en) | 2012-07-30 | 2013-07-30 | Protein kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205507A1 true HK1205507A1 (en) | 2015-12-18 |
Family
ID=49995471
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106057.0A HK1205506A1 (en) | 2012-07-30 | 2015-06-25 | Protein kinase inhibitors |
HK15106058.9A HK1205507A1 (en) | 2012-07-30 | 2015-06-25 | Protein kinase inhibitors |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106057.0A HK1205506A1 (en) | 2012-07-30 | 2015-06-25 | Protein kinase inhibitors |
Country Status (7)
Country | Link |
---|---|
US (1) | US8859553B2 (de) |
EP (1) | EP2880038B1 (de) |
JP (2) | JP2015523402A (de) |
CN (1) | CN104470934B (de) |
ES (1) | ES2673231T3 (de) |
HK (2) | HK1205506A1 (de) |
WO (1) | WO2014019338A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2477723C2 (ru) | 2011-06-16 | 2013-03-20 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
JP2017525727A (ja) * | 2014-08-26 | 2017-09-07 | アスター バイオテック リミテッド ライアビリティ カンパニー | プロテインキナーゼ阻害剤 |
CN104327083A (zh) * | 2014-09-12 | 2015-02-04 | 辽宁大学 | 取代二氢茚酰胺类化合物及其药学上可接受的盐及制备方法和应用 |
CN106167491A (zh) * | 2015-05-19 | 2016-11-30 | 重庆大学 | 一种有效抑制肺癌转移的化合物及其应用 |
CN107226809A (zh) * | 2016-03-23 | 2017-10-03 | 浙江大德药业集团有限公司 | 酪氨酸激酶抑制剂 |
CN107353286A (zh) * | 2016-05-10 | 2017-11-17 | 北京生命科学研究所 | 新型咪唑并[1,2-b]哒嗪酰胺类Bcr-Abl激酶抑制剂及其制备方法和应用 |
CN108456163A (zh) * | 2017-02-20 | 2018-08-28 | 中国科学院上海药物研究所 | 含邻氨基杂芳环炔基的化合物及其制备方法和用途 |
JP2022537833A (ja) * | 2019-06-24 | 2022-08-30 | ベネボレントエーアイ バイオ リミティド | 新規化合物と方法 |
JP2024513227A (ja) | 2021-04-05 | 2024-03-22 | ハリア・セラピューティクス・インコーポレイテッド | Nek7阻害剤 |
BR112023021215A2 (pt) * | 2021-04-13 | 2023-12-19 | Shenzhen Newdel Biotech Co Ltd | Compostos de alquinilfenilbenzamida, usos dos mesmos e composição farmacêutica compreendendo os referidos compostos |
WO2022226182A1 (en) | 2021-04-22 | 2022-10-27 | Halia Therapeutics, Inc. | Nek7 inhibitors |
CN113666876B (zh) * | 2021-07-05 | 2023-09-29 | 佛山市南海北沙制药有限公司 | 一种磺胺氯哒嗪的生产工艺 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH504505A (de) * | 1966-08-15 | 1971-03-15 | Ciba Geigy Ag | Verwendung von neuen Tolanderivaten als optische Aufhellmittel ausserhalb der Textilindustrie |
GB9218334D0 (en) * | 1992-08-28 | 1992-10-14 | Ici Plc | Heterocyclic compounds |
US5455260A (en) * | 1993-05-21 | 1995-10-03 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Aliphatic amino bis-aryl squalene synthase inhibitors |
JP3990061B2 (ja) * | 1998-01-05 | 2007-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | プリン誘導体および糖尿病の予防・治療剤としてのアデノシンa2受容体拮抗剤 |
US7459454B2 (en) * | 2003-03-21 | 2008-12-02 | Smithkline Beecham Corporation | Aminopyrazine derivatives and compositions |
TW200530368A (en) * | 2003-10-01 | 2005-09-16 | Ube Industries | Heterocyclic ring substituded phenylacetylene compound, method for producing the same and organic electroluminescence element using the same |
US7776869B2 (en) * | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
JP2008534439A (ja) * | 2005-01-28 | 2008-08-28 | メルク エンド カムパニー インコーポレーテッド | チェックポイントキナーゼの阻害剤 |
CN101115724A (zh) * | 2005-02-08 | 2008-01-30 | 默克公司 | 关卡激酶抑制剂 |
CN101163675A (zh) * | 2005-04-19 | 2008-04-16 | 协和发酵工业株式会社 | 含氮杂环化合物 |
GB0520164D0 (en) * | 2005-10-04 | 2005-11-09 | Novartis Ag | Organic compounds |
WO2007056155A1 (en) * | 2005-11-03 | 2007-05-18 | Chembridge Research Laboratories, Inc. | Heterocyclic compounds as tyrosine kinase modulators |
JP5200939B2 (ja) * | 2005-12-23 | 2013-06-05 | アリアド・ファーマシューティカルズ・インコーポレイテッド | 二環式ヘテロアリール化合物 |
GB0602178D0 (en) * | 2006-02-03 | 2006-03-15 | Merck Sharp & Dohme | Therapeutic treatment |
WO2008047831A1 (fr) * | 2006-10-17 | 2008-04-24 | Kyowa Hakko Kirin Co., Ltd. | Inhibiteurs de JAK |
CN101743237A (zh) * | 2007-07-16 | 2010-06-16 | 先正达参股股份有限公司 | 稠合的邻氨基苯甲酰胺杀虫剂 |
JP2011507851A (ja) * | 2007-12-19 | 2011-03-10 | ザ スクリプス リサーチ インスティチュート | Rhoキナーゼインヒビターとしてのベンゾイミダゾールおよびアナログ |
US9180127B2 (en) * | 2009-12-29 | 2015-11-10 | Dana-Farber Cancer Institute, Inc. | Type II Raf kinase inhibitors |
US8962631B2 (en) * | 2010-05-12 | 2015-02-24 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
CN101885722B (zh) * | 2010-07-01 | 2013-07-24 | 中国科学院广州生物医药与健康研究院 | 杂环炔苯类化合物及其药用组合物和应用 |
WO2012089106A1 (zh) * | 2010-12-27 | 2012-07-05 | Sun Shuping | 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途 |
RU2477723C2 (ru) * | 2011-06-16 | 2013-03-20 | Общество С Ограниченной Ответственностью "Фьюжн Фарма" | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе |
CN102584830A (zh) * | 2011-12-30 | 2012-07-18 | 北京赛林泰医药技术有限公司 | 二氢化茚酰胺化合物、其药物组合物及其用途 |
JP2015514802A (ja) * | 2012-04-25 | 2015-05-21 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Rafキナーゼ媒介疾患用の方法及び組成物 |
CN102775411A (zh) * | 2012-08-17 | 2012-11-14 | 浙江大德药业集团有限公司 | 作为蛋白激酶抑制剂的芳乙炔基苯甲酰胺类化合物 |
-
2012
- 2012-07-30 US US13/561,960 patent/US8859553B2/en active Active
-
2013
- 2013-07-30 CN CN201380038289.XA patent/CN104470934B/zh active Active
- 2013-07-30 EP EP13824937.0A patent/EP2880038B1/de active Active
- 2013-07-30 WO PCT/CN2013/000897 patent/WO2014019338A1/en active Application Filing
- 2013-07-30 JP JP2015524599A patent/JP2015523402A/ja active Pending
- 2013-07-30 ES ES13824937.0T patent/ES2673231T3/es active Active
-
2015
- 2015-06-25 HK HK15106057.0A patent/HK1205506A1/xx unknown
- 2015-06-25 HK HK15106058.9A patent/HK1205507A1/xx not_active IP Right Cessation
-
2016
- 2016-10-21 JP JP2016207102A patent/JP6308504B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
US8859553B2 (en) | 2014-10-14 |
HK1205506A1 (en) | 2015-12-18 |
JP2017039765A (ja) | 2017-02-23 |
EP2880038B1 (de) | 2018-05-16 |
ES2673231T3 (es) | 2018-06-20 |
JP6308504B2 (ja) | 2018-04-11 |
EP2880038A1 (de) | 2015-06-10 |
JP2015523402A (ja) | 2015-08-13 |
WO2014019338A1 (en) | 2014-02-06 |
CN104470934B (zh) | 2017-08-04 |
US20140031354A1 (en) | 2014-01-30 |
CN104470934A (zh) | 2015-03-25 |
EP2880038A4 (de) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1215577A1 (zh) | 蛋白激酶抑制劑 | |
HK1217198A1 (zh) | 蛋白激酶抑制劑 | |
HK1200451A1 (zh) | 蛋白激酶抑制劑 | |
HK1210775A1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
HK1208442A1 (en) | Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors mknk | |
EP2694517A4 (de) | Proteinkinase-hemmer | |
HK1200828A1 (en) | Kinase inhibitors | |
HUE048834T2 (hu) | Kináz inhibitorok | |
ZA201306855B (en) | Protein kinase inhibitors | |
HK1209726A1 (en) | Protein kinase inhibitors | |
HK1205506A1 (en) | Protein kinase inhibitors | |
EP2833889A4 (de) | Proteinkinase-c-hemmer und verwendungen davon | |
HK1218119A1 (zh) | 蛋白激酶抑制劑 | |
IL229028A0 (en) | Kinase inhibitors | |
HK1208460A1 (en) | Protein kinase inhibitors | |
HK1199873A1 (en) | Kinase inhibitors | |
SG11201500973WA (en) | Amino-quinolines as kinase inhibitors | |
IL230504A0 (en) | Selective protein kinase inhibitors | |
EP2879679A4 (de) | Antibakterielle proteinkinasehemmer | |
HK1210036A1 (en) | Aminoisoquinoline derivatives as protein kinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230801 |